Antigen-based metric could better predict which patients benefit from immunotherapy, study says
MATTHEW DANIELS/WELLCOME
The new metric looks at the specific genetic profiles of each neoantigen to sort out which ones might bode well for treatment.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario